Table 1.
Clinicopathological features of resectable and unresectable pancreatic adenocarcinoma patients
| Characteristics | Total (n) | Resectable (n, %) | Unresectable (n, %) | P |
|---|---|---|---|---|
| Numbers of cases | 302 | 150 | 152 | |
| Age (mean ± SD, years) | 61.7 ± 9.4 | 61.6 ± 8.4 | 61.9 ± 10.2 | 0.785 |
| Gender | ||||
| Male | 188 | 84 (44.7) | 104 (55.3) | 0.026 |
| Female | 114 | 66 (57.9) | 48 (42.1) | |
| Tumor location | ||||
| Head | 188 | 86 (45.7) | 102 (54.3) | 0.186 |
| Body | 87 | 49 (56.3) | 38 (43.7) | |
| Tail | 26 | 15 (57.7) | 11 (42.3) | |
| Tumor size | ||||
| ≤ 3 cm | 104 | 54 (51.9) | 50 (48.1) | 0.648 |
| 3-6 cm | 151 | 71 (47.0) | 80 (53.0) | |
| ≥ 6 cm | 47 | 25 (53.2) | 22 (46.8) | |
| AFP | ||||
| ≤ 10 ng/ml | 286 | 144 (50.3) | 142 (49.7) | 0.978 |
| > 10 ng/ml | 16 | 8 (50.0) | 8 (50.0) | |
| CEA | ||||
| ≤ 5 ng/ml | 187 | 103 (55.1) | 84 (44.9) | 0.011 |
| > 5 ng/ml | 115 | 46 (40.0) | 69 (60.0) | |
| CA 125 | ||||
| ≤ 35 U/ml | 180 | 106 (58.9) | 74 (41.1) | 0.001 |
| > 35 U/ml | 122 | 47 (38.5) | 75 (61.5) | |
| CA 199 | ||||
| ≤ 37 U/ml | 68 | 38 (55.9) | 30 (44.1) | 0.244 |
| > 37 U/ml | 234 | 112 (47.9) | 122 (52.1) | |
| CA 242 | ||||
| ≤ 15 U/ml | 106 | 54 (50.9) | 52 (49.1) | 0.876 |
| > 15 U/ml | 196 | 98 (50.0) | 98 (50.0) | |
| CA 724 | ||||
| ≤ 6.9 U/ml | 180 | 122 (67.8) | 58 (32.2) | < 0.001 |
| > 6.9 U/ml | 122 | 28 (23.0) | 94 (77.0) |
Bold values are statistically significant (P < 0.05).